HYDROCORTISONE (HC) WITH OR WITHOUT MITOXANTRONE (M) IN PATIENTS (PTS) WITH HORMONE-REFRACTORY PROSTATE-CANCER (HRPC) - PRELIMINARY-RESULTSFROM A PROSPECTIVE RANDOMIZED CANCER AND LEUKEMIA GROUP-B STUDY (9182) COMPARING CHEMOTHERAPY TO BEST SUPPORTIVE CARE

Authors
KANTOFF PW CONAWAY M WINER E PICUS J VOGELZANG NJ
Citation
Pw. Kantoff et al., HYDROCORTISONE (HC) WITH OR WITHOUT MITOXANTRONE (M) IN PATIENTS (PTS) WITH HORMONE-REFRACTORY PROSTATE-CANCER (HRPC) - PRELIMINARY-RESULTSFROM A PROSPECTIVE RANDOMIZED CANCER AND LEUKEMIA GROUP-B STUDY (9182) COMPARING CHEMOTHERAPY TO BEST SUPPORTIVE CARE, Journal of clinical oncology, 14(5), 1996, pp. 2013-2013
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Journal of clinical oncology → ACNP
ISSN journal
0732183X
Volume
14
Issue
5
Year of publication
1996
Pages
2013 - 2013
Database
ISI
SICI code
0732-183X(1996)14:5<2013:H(WOWM>2.0.ZU;2-O